Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $17.3M oversubscribed Series B (Mar 2026). Profitable in 2025. 140%+ NRR. Protects $2T+ assets monthly. #1 adverse media solution two consecutive years (Chartis).
Sigma360 is an AI risk intelligence platform providing adverse media screening, regulatory risk assessment, and financial crime intelligence to banks, asset managers, and regulated financial institutions. The company raised $17.3 million in an oversubscribed Series B in March 2026, reporting profitability in 2025 and 140%+ net revenue retention — metrics that are exceptional for a growth-stage financial crime technology company in any market environment.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.